“The pre-clinical study, which was conducted on swine over a two-week period, examined BloodSTOP iX Battle Matrix’s effectiveness in stopping the bleeding using a standard military and FDA approved protocol: a 6mm arteriotomy made to the femoral artery using a vascular punch. BloodSTOP iX was the only hemostatic wound-care product in the study to achieve a 100% survival rate — meaning all of the pigs that were treated with BloodSTOP iX survived.”